Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan 5;23(2):234-238.
doi: 10.1002/chem.201604792. Epub 2016 Nov 2.

Metal Complexes for Two-Photon Photodynamic Therapy: A Cyclometallated Iridium Complex Induces Two-Photon Photosensitization of Cancer Cells under Near-IR Light

Affiliations

Metal Complexes for Two-Photon Photodynamic Therapy: A Cyclometallated Iridium Complex Induces Two-Photon Photosensitization of Cancer Cells under Near-IR Light

Luke K McKenzie et al. Chemistry. .

Abstract

Photodynamic therapy (PDT) uses photosensitizers (PS) which only become cytotoxic upon light-irradiation. Transition-metal complexes are highly promising PS due to long excited-state lifetimes, and high photo-stabilities. However, these complexes usually absorb higher-energy UV/Vis light, whereas the optimal tissue transparency is in the lower-energy NIR region. Two-photon excitation (TPE) can overcome this dichotomy, with simultaneous absorption of two lower-energy NIR-photons populating the same PS-active excited state as one higher-energy photon. We introduce two low-molecular weight, long-lived and photo-stable iridium complexes of the [Ir(N^C)2 (N^N)]+ family with high TP-absorption, which localise to mitochondria and lysosomal structures in live cells. The compounds are efficient PS under 1-photon irradiation (405 nm) resulting in apoptotic cell death in diverse cancer cell lines at low light doses (3.6 J cm-2 ), low concentrations, and photo-indexes greater than 555. Remarkably 1 also displays high PS activity killing cancer cells under NIR two-photon excitation (760 nm), which along with its photo-stability indicates potential future clinical application.

Keywords: cancer therapy; iridium; singlet oxygen; transition metals; two-photon photodynamic therapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Complexes 1 and 2.
Figure 2
Figure 2
Subcellular localisation of 1. U2OS cells following 4 or 24 hour incubation with 1 (green), co‐localised with: A) Mitotracker orange (red), or B) Lysotracker (red). Zoomed sections are shown as insets. Scale bars=20 μm.
Figure 3
Figure 3
One‐photon‐induced PS activities of complexes 1 and 2. A) Survival of HeLa cells pre‐incubated for 2 or 24 h with complexes 1 or 2 +/− light. B) Anexin V staining in HeLa cells. C) Survival of bladder (EJ), osteosarcoma (U2OS), melanoma (A375) and colorectal (HCT116) cancer cells 1 +/− light treatment.
Figure 4
Figure 4
Two‐photon‐induced PS activity of 1. HeLa cells treated with 1 or DMSO 2 h before irradiation of a central square with 760 nm multiphoton laser. After 24 h cells were stained with markers for apoptosis (Annexin V, red) and cell death (propidium iodide, green). All images are 450×450 μm except those in the 0 mW column which are 900×900 μm.

References

    1. O′Connor A. E., Gallagher W. M., Byrne A. T., Photochem. Photobiol. 2009, 85, 1053–1074. - PubMed
    1. Castano A. P., Demidova T. N., Hamblin M. R., Photodiagn. Photodyn. Therapy 2005, 2, 1–23. - PMC - PubMed
    1. None
    1. Mackay F. S., Woods J. A., Moseley H., Ferguson J., Dawson A., Parsons S., Sadler P. J., Chem. Eur. J. 2006, 12, 3155–3161; - PubMed
    1. Mackay F. S., Woods J. A., Heringová P., Kašpárková J., Pizarro A. M., Moggach S. A., Parsons S., Brabec V., Sadler P. J., Proc. Natl. Acad. Sci. USA 2007, 104, 20743–20748; - PMC - PubMed

Publication types